Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phenoxodiol studied in new ovarian cancer trial

April 26, 2004

Advexin subject of new SWOG phase II trial

April 23, 2004

CG-53135 enters new phase I trial in bone marrow transplant patients

April 23, 2004

MedImmune and Cerus to codevelop novel therapeutic vaccine

April 23, 2004

BTG licenses abiraterone acetate rights to Cougar

April 23, 2004

Improved pharmacokinetics, antitumor activity and tolerability for liposomal vinorelbine

April 23, 2004

Novel Raf kinase inhibitors under study at Merck KGaA

April 23, 2004

In vitro, in vivo and pharmacodynamic evaluations of Flt-3/KDR inhibitor

April 23, 2004

Genasense available through Expanded Access Program for advanced melanoma

April 22, 2004

Bristol-Myers Squibb receives North American and Asian license for Javlor

April 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...